Physical branch meetings are currently cancelled due to COVID-19. However there are virtual activities being run by some branches. Please contact your local branch for more information.

We hope you find the information on these pages helpful. Our team is working tirelessly to provide up to date advice in relation to the COVID-19/Coronavirus pandemic. Record numbers of people are now turning to NASS for support, and we hope to be here for everyone. Our helpline and advice service are only possible thanks to donations from people like you.

If you are able to make a donation to NASS today, we'd be so grateful.



Search results for: 'biosimilar'


Discover the role of biosimilars in the treatment of axial SpA (AS)

Every Patient, Every Time

NASS knows that not everyone in the UK gets the same standard of care for their axial SpA (AS) – that’s why we've launched our new campaign Every Patient, Every Time.

Working with NICE & SMC

NASS works closely with the National Institute for Health and Care Excellence and Scottish Medicines Consortium, contributing to the development of the Guideline and Quality Standard for Spondyloarthritis, and offering patient perspective on drug appraisals


Discover the role of NSAIDs in managing axial SpA (AS)


Discover the role of DMARDs in managing axial SpA (AS)

Biologic Therapy

Discover the role of biologic therapy in managing axial SpA (AS)